Noah Doyle is Director at RITTER PHARMACEUTICALS INC (RTTR). They have made 2 open-market trades across 1 company since 2015, most recently 2020-03-12.
CIK 0001631673
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.0M since 2015, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RTTR | 704,780 | $7.9M |
Shares reported on the most recent Form 4, priced at the 2020-03-16 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.